I think what you'll find is the Baker IDI's research is based on newly diagnosed T1D. Adolescents with still functioning beta cells.
When I look at the recruitment criteria, it's pretty strict for these individuals.
Long term T1D patients are still stuck.
I imagine the work Dr Coates has been doing with BTM for T1D, is beneficial for a wider audience.
PNV Media Thread, page-2938
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.74 |
Change
0.060(2.24%) |
Mkt cap ! $1.891B | |||
| Open | High | Low | Value | Volume |
| $2.69 | $2.75 | $2.66 | $1.705M | 627.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 28 | 21407 | $2.74 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.75 | 114930 | 25 |
View Market Depth
| Last trade - 11.59am 01/08/2024 (20 minute delay) ? |
| PNV (ASX) Chart |